Clinical Trial Failure Isn’t an Inevitable Risk—It’s Insurable and Opening the Door to New Investors
Clinical trial failure insurance is turning biotech’s most costly risk into a manageable asset, opening new pathways for funding and innovation.
Natalie Marquess, ARM, CIC, CRM
Advertisement
Director - Business Development, Life Sciences at Aon
Articles by Natalie Marquess, ARM, CIC, CRM
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Reportedly Pauses Commissioner’s National Priority Voucher Pilot as Existing Reviews Continue
2
Why So Many Patients From Underrepresented Groups Are Never Asked to Join a Trial
3
How Inconsistent Screening Shapes Which Oncology Patients Get Flagged for Trials
4
ACT Brief: Zip Code Trial Access, Smaller Biotech APAC Perceptions, and Pimjetmi Tumor Approval
5